Skip to content

Tag: Corneal endothelial cell loss

Explore our medication guides and pharmacology articles within this category.

Is Durysta Safe? A Comprehensive Look at the Glaucoma Implant

5 min read
The FDA approved Durysta in March 2020 as the first biodegradable, sustained-release implant for glaucoma, offering an alternative to daily eye drops. However, patients and healthcare providers must weigh the potential advantages against the safety profile to answer the critical question: 'Is Durysta safe?'